立体定向引导可扩张内镜端口手术治疗深部脑肿瘤:技术报告与病例对照系列分析
研究纳入8例深部脑肿瘤患者(6例胶质囊肿、1例转移瘤、1例脑室内脑膜瘤),采用立体定向引导可扩张端口系统(DEPS)经脑针轨迹建立手术通道,并与标准内镜端口手术病例匹配队列比较。所有患者均实现全切除且无新发神经功能缺损,DEPS组残留穿刺道缺损显著更小(P < 0.05),但术后3个月T2加权信号改变及弥散受限体积无显著差异(P > 0.05)。作者认为DEPS可能是深部脑肿瘤的安全替代方案,但需更大样本验证。
要点
- DEPS经2.6-mm立体定向针轨迹、球囊扩张至14 mm建立通道,8例均全切除且无新发神经功能缺损。
- DEPS组残留穿刺道缺损显著小于标准内镜端口手术组(P < 0.05)。
- 术后3个月T2加权信号改变及弥散受限体积两组无显著差异(P > 0.05),作者认为需更大样本验证。
核心结论
- DEPS可能是深部脑肿瘤标准内镜端口手术或显微手术的安全替代方案。
- 基于MRI分析,DEPS的医源性损伤程度可能等同于或小于标准端口手术技术,但需更大样本验证。
研究设计与样本
- 技术报告与病例对照系列分析,纳入8例深部脑肿瘤患者(6例胶质囊肿、1例转移瘤、1例脑室内脑膜瘤),其中5例采用无框架、3例采用框架立体定向靶向。
- 使用经脑沟轨迹和2.6-mm立体定向针,在目标深度移除套管并将球囊扩张至14 mm,球囊放气移除后置入端口。
- 采用术前和术后3个月MRI测量T2加权信号改变和残留穿刺道缺损,并与病例匹配的标准内镜端口手术队列比较。
主要发现
- 所有患者均实现病灶全切除,无新发神经功能缺损。
- DEPS组残留穿刺道缺损显著小于标准内镜端口手术组(P < 0.05)。
- 术后3个月T2加权信号改变及弥散受限体积两组无显著差异(P > 0.05)。
临床怎么用
- 作者认为DEPS可能是深部脑肿瘤标准内镜端口手术或显微手术的安全替代方案。
- 作者认为DEPS的医源性损伤程度可能等同于或小于标准端口手术技术,但需更大样本验证。
局限性
- 原文指出需要更大样本量进行验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Deep-seated brain tumors are often best treated by primary surgical excision. Traditional microsurgical techniques can cause retraction injury and require extensive brain dissection. To mitigate this risk, stereotactic-guided tubular retractors were developed; however, the risk of shear injury remains. We created a stereotactic-guided dilatable port system to create a corridor for deep brain tumor surgery along the trajectory of a brain needle to minimize iatrogenic brain injury. METHODS: Of the 8 included patients (6 colloid cysts, 1 metastasis, 1 intraventricular meningioma), 5 had undergone frameless and 3 frame-based stereotactic targeting. We used a tans-sulcal trajectory and a 2.6-mm stereotactic needle. At the target depth, the cannula was removed and the balloon inflated to 14 mm. The balloon was deflated and removed before placing the port. Pre- and 3-month postoperative magnetic resonance imaging scans were used to measure the T2-weighted signal change and residual cannulation defect. These patients were compared with a case-matched standard endoscopic port surgery cohort. RESULTS: All patients had undergone total lesional resection without new neurologic deficits. Patients undergoing dilatable endoscopic port surgery (DEPS) had significantly smaller residual cannulation defects (P < 0.05) but no significant differences in postoperative T2-weighted signal changes or diffusion restriction volumes at 3 months postoperatively (P > 0.05). CONCLUSIONS: DEPS might be a safe alternative to standard endoscopic port surgery or microsurgery for deep-seated brain tumors. The degree of iatrogenic injury using DEPS, as determined by magnetic resonance imaging analysis, might be equivalent to or less than that with standard port surgery techniques, although larger sample sizes are needed for validation.
引用
- Newman WC, Engh JA. Stereotactic-Guided Dilatable Endoscopic Port Surgery for Deep-Seated Brain Tumors: Technical Report with Comparative Case Series Analysis. World Neurosurg. 2019. PMID: 30738944. doi:10.1016/j.wneu.2019.01.175
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。